Product/Composition:- | Diclofenac Diethylamine Topical Gel/Emulsion |
---|---|
Strength:- | 1%, 2% |
Form:- | Topical Gel/Emulsion |
Reference Brands:- | Voltaren Emulgel, Pennsaid(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Diclofenac Diethylamine topical gel inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include targeted pain relief, rapid onset, fewer systemic side effects, and improved joint mobility. Ideal for localized musculoskeletal conditions with convenient, non-invasive application.
Diclofenac Diethylamine topical gel/emulsion is approved in both the EU and US for localized musculoskeletal pain and inflammation. In the EU, brands like Voltaren are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, pharmacovigilance, and quality assurance. Both regions enforce strict regulations, including proper labeling, usage guidelines, and monitoring for adverse effects. For expert guidance on regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for diclofenac diethylamine gel/emulsion, ensuring adherence to European and US standards for safe, effective local anti-inflammatory therapy.